Skip to content

Dr. JÖRGEN JOOS

Active
Private limited companyfounded 2006active for 20 yearsBrugsesteenweg 2, 9900 Eeklo, BelgiumKBO/BCE: BE 0883.097.601

From the official registers: KBO 19 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. JÖRGEN JOOS has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €950,334 and a net result of €126,973. Equity has been growing by about 13% per year since 2019. Its solvency ranks better than 68% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 16-08-2006 Normal situation
Legal form
Private limited company
Registered office
Brugsesteenweg 2, 9900 Eeklo
Activity
General medical practice NACE 86210
Establishment unit
2.159.887.914 9900 Eeklo, since 28-02-2007
Financial year end
31 March
Peppol
Not found in the Peppol Directory

Board and ownership

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 31-03-2025
Gross margin
€231,043
▲ 15.8%
Turnover
≈ €420,000
estimated
Profit
€126,973
▲ 16.5%
Equity
€950,334
▲ 2.9%
Total assets
€1.2m
▲ 13.0%
Staff
1 FTE
=
2026 accounts not filed, 1 day past the deadline
Filed on 30-10-2025PDF
Score breakdownraises riskFigures for financial year 2025 (filed on 01-11-2025)lowers riskLiquidity: current ratio 3.86, cash €572,581Sector: Human health activities (NACE 86)Equity €950,334 (78.4% of total assets)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 59% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 78.4% of total assets
Liquidity 93=
short-term debt 20.8% · cash 47.2%
Profitability 82+1
return on assets 10.5%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025highest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026lowest value 04-2026: < 0.1%● unchanged vs 03-2026lowest value 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €90,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.86 (5.64 in 2024), above the usual 1.5. Short-term debt is 20.8% and cash 47.2% of total assets. 21.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 80% on liquidity, 29% on profitability and 43% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 3.86, cash €572,581
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Equity €950,334 (78.4% of total assets)
NBB · annual accounts
raises risk · Figures for financial year 2025 (filed on 01-11-2025)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 30-10-2025, 1 day ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2026
not filed
2025
1 day early
2024
3 days early
2023
1 day early
2022
16 days late
2021
2 days early
2020
5 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 6 accounts on average 1 day after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: More equity than 93% of companies in human healthsector median €124,628 · 20,680 companies €950,334 View
  • Positive: 7 profitable years in a rowprofit 2025: €126,973 7 years View

Documents

Annual accounts at the NBB

All 19 annual accounts

Articles and registers

Key facts about Dr. JÖRGEN JOOS

What is the company number of Dr. JÖRGEN JOOS?
The company number of Dr. JÖRGEN JOOS is 0883.097.601. The VAT number is the same number with BE in front: BE 0883.097.601.
Where is Dr. JÖRGEN JOOS based?
The registered office is at Brugsesteenweg 2, 9900 Eeklo.Company details
What does Dr. JÖRGEN JOOS do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. JÖRGEN JOOS?
The legal form of Dr. JÖRGEN JOOS is Private limited company (BV).
When was Dr. JÖRGEN JOOS founded?
Dr. JÖRGEN JOOS was founded on 16-08-2006.
Is Dr. JÖRGEN JOOS still active?
Yes, Dr. JÖRGEN JOOS is an active enterprise in the KBO register.
How many employees does Dr. JÖRGEN JOOS have?
Dr. JÖRGEN JOOS had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Dr. JÖRGEN JOOS?
The turnover in financial year 2025 is ≈ €420,000. This figure is estimated from the gross margin of €231,043 and 30 comparable companies (NACE 86210). It probably lies between €340,000 and €520,000.
Is Dr. JÖRGEN JOOS profitable?
In financial year 2025, Dr. JÖRGEN JOOS made a profit of €126,973.
Where can I find the annual accounts of Dr. JÖRGEN JOOS?
Dr. JÖRGEN JOOS filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)

Comparable companies

These companies have the same main activity as Dr. JÖRGEN JOOS: general medical practice (NACE 86210). They are comparable in size and age: total assets between €1.2m and €1.3m, founded between 2003 and 2008.

CompanyTotal assetsGross margin
Dr. JÖRGEN JOOS Eeklo€1.2m€0.2m
DOKTER BONAMI Aalter€1.3m€0.2m
Dr. Sophie De Cauwer Sint-Gillis-Waas€1.2m€0.2m
HUISARTSENPRAKTIJK BART MERCKX Sint-Niklaas€1.2m€0.2m
Dr. G. De Lendtdecker Antwerpen€1.2m€0.2m
DOKTER MARTINE HUYBRECHTS,algemene geneeskunde Wemmel€1.3m€0.2m
Dokter Ben Janssen Hechtel-Eksel€1.3m€0.2m
Full comparison

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.